The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
U.S. Department of Health and Human Services
Health Resources and Services Administration
  • YouTube
  • HRSA eNews
  • Print this
  • Email this

Job and Advisory Committee Opportunities

Request for Nominations for ACCV Voting Members

HRSA is requesting nominations for voting members to serve on the Advisory Commission on Childhood Vaccines (ACCV). Read the Federal Register notice (PDF). 

The ACCV advises the Secretary on the implementation of the National Vaccine Injury Compensation Program (VICP). The ACCV consists of nine voting members appointed by the Secretary. HRSA is requesting nominations for voting members of the ACCV representing:

(1) three health professionals, who have expertise in the health care of children, the epidemiology, etiology, and prevention of childhood diseases, and the adverse reactions associated with vaccines, of whom both shall be a pediatricians;
(2) three members of the general public, of whom at least two shall be legal representative (parent or guardian) of a child who has suffered a vaccine related injury or death ; and
(3) three attorneys, of whom at least one shall be an attorney whose specialty includes representation of persons who have suffered a vaccine-related injury or death, and of whom one shall be an attorney whose specialty includes representation of vaccine manufacturers.

Based on a recommendation made by the ACCV, the Secretary will consider having a health professional with expertise in obstetrics as the second member of the general public.

Nominees will be invited to serve a 3‑year term beginning the date of appointment.

ACCV members are appointed as Special Government Employees. As such, they are covered by the federal ethics rules, including the criminal conflict of interest statutes governing executive branch employees.

For example, an ACCV member may be prohibited from discussions about making changes to the Vaccine Injury Table and Vaccine Information Statements for the Hepatitis B vaccine if he/she or his/her spouse owns stock valued above a certain amount in companies which manufacturer this vaccine, affecting their own pecuniary interests - including interests imputed to them.

To evaluate possible conflicts of interest, potential candidates will be asked to fill out the Confidential Financial Disclosure Report, OGE Form 450, to provide detailed information concerning financial interests, consultancies, research grants, and/or contracts that might be affected by recommendations made by the ACCV.

All nominations are to be submitted to the address below:

Director, Division of Injury Compensation Programs
Healthcare Systems Bureau
Health Resources and Services Administration
5600 Fishers Lane
Room 08N146B
Rockville, MD 20857

For further information contact Ms. Annie Herzog, Principal Staff Liaison at 301-443-6634 or by email at aherzog@hrsa.gov.

Last Reviewed: April 2016